Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome

3Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.
Get full text

Abstract

New-onset refractory status epilepticus (NORSE) is a drug-resistant status epilepticus that often has a catastrophic outcome. Our patient was diagnosed with NORSE and had an EEG reading that showed status epilepticus persisting for 8 months in general anesthesia. After autoimmune workup showed positive antiphospholipid antibodies, his seizure was controlled, and he was discharged with good condition apart from moderate cognitive impairment. However, he later developed schizophrenia. Although psychiatric disorders have been associated with antiphospholipid syndrome, to the best of our knowledge, it has not been reported to be associated with status epilepticus. We recommend vigilance of psychological complications of refractory status epilepticus’ patients for early psychiatric referral, diagnosis, and treatment.

Cite

CITATION STYLE

APA

Al-Khateeb, M. O., Adem, F., Moqbel, A., & Baz, S. (2019). Schizophrenia following new-onset refractory status epilepticus secondary to antiphospholipid syndrome. Neurosciences, 24(3), 240–244. https://doi.org/10.17712/nsj.2018.3.20180014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free